Unique ID issued by UMIN | UMIN000028032 |
---|---|
Receipt number | R000032097 |
Scientific Title | Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI |
Date of disclosure of the study information | 2017/09/01 |
Last modified on | 2020/10/03 17:14:44 |
Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Assessment of treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Japan |
Hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
The aim of this study is to clarify a relationship between local recurrence of the hepatocellular carcinoma and treatment area by transcatheter arterial chemoembolization under administration of SPIO using MRI
Efficacy
local recurrence
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
MRI scan under administration of SPIO before transcatheter arterial chemoembolization.
MRI scan 3 to 5 days after the transcatheter arterial chemoembolization
20 | years-old | <= |
Not applicable |
Male and Female
1)Diagnosis of hepatocellular carcinoma according to EASL guideline
2)Chemoembolization is indicated.
3)Performance status of 0-2
4)Liver function of Child-pugh A or B
5)eGFR is 30mL/min/1.73m2 or more
6)Platelet count of 50,000 microL or more
7)No previous treatment or 4 weeks after the previous treatment
8)Informed consent is obtained.
1)Rupture of hepatocellular carcinoma
2)History of surgical or endoscopic treatment of bile duct
3)Prominent arterioportal or arteriovenous shunts
4)Dissection or stenosis of 50% or more in the celiac trunk or hepatic artery
5)Hepatic coma or severe psychiatric disorder
6)Severe drug allergy including SPIO or iodine contast allergy
7)Inadequate patients to undergo the procedure safely
30
1st name | |
Middle name | |
Last name | Sodai Hoshiai |
Faculty of Medicine, University of Tsukuba
Department of Radiology
1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575 Japan
0298533205
hoshiai@md.tsukuba.ac.jp
1st name | |
Middle name | |
Last name | Sodai Hoshiai |
Faculty of Medicine, University of Tsukuba
Department of Radiology
1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575 Japan
0298533205
hoshiai@md.tsukuba.ac.jp
University of Tsukuba
University of Tsukuba
Japanese Governmental office
NO
2017 | Year | 09 | Month | 01 | Day |
Unpublished
Terminated
2017 | Year | 09 | Month | 01 | Day |
2017 | Year | 09 | Month | 28 | Day |
2017 | Year | 09 | Month | 28 | Day |
2020 | Year | 11 | Month | 30 | Day |
2017 | Year | 07 | Month | 01 | Day |
2020 | Year | 10 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032097
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |